Release Date: 21/03/11 16:53 Summary: GGG Resources PLC - Second Supplementary Prospectus Price Sensitive: No Download Document 623.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%